Health & Fitness
Health and Fitness
Health and Fitness
Tue, November 17, 2009
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
[ Tue, Nov 17th 2009
] - Market Wire
Mon, November 16, 2009
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
[ Mon, Nov 16th 2009
] - Market Wire
Sun, November 15, 2009
[ Sun, Nov 15th 2009
] - Market Wire
Fri, November 13, 2009
[ Fri, Nov 13th 2009
] - Market Wire
[ Fri, Nov 13th 2009
] - Market Wire
BioSyntech announces second quarter fiscal 2010 financial results
- Appointed Ms. Jeanne M. Bertonis to the position of Chief Executive Officer and Ms. Antoinette Lizzi to the position of Chief Financial Officer. - Raised $1.4 million in a non-brokered private placement consisting of 140,000 units of BioSyntech, each comprised of $10 principal amount of subordinated secured convertible debentures and 91 common share purchase warrants at a price of $10 per Unit. - Subsequent to quarter-end, closed rights offering for gross aggregate proceeds of $3.1 million. - Interim analysis of clinical data from 41 patients in the ongoing Canadian/European clinical trial is being finalized, including MRI data.
Contributing Sources
